The FDA has granted approval for the use of vorasidenib in the treatment of Grade 2 astrocytoma or oligodendroglioma in patients having a specific IDH1 or IDH2 mutation
August 2024: Vorasidenib (Voranigo, Servier Pharmaceuticals LLC), an inhibitor of isocitrate dehydrogenase-1 (IDH1) and isocitrate dehydrogenase-2 (IDH2), has been approved by the Food and Drug Administration for the treatment of ..
The FDA has granted accelerated approval to afamitresgene autoleucel for the treatment of unresectable or metastatic synovial sarcoma
August 2024: The Food and Drug Administration has given accelerated approval to afamitresgene autoleucel (TECELRA, Adaptimmune, LLC), a genetically modified autologous T cell immunotherapy that targets the melanoma-associated anti..
The FDA Approved The First Engineered T Cell Therapy for Solid Tumors
August 2024: The United States Food and Drug Administration (FDA) awarded fast approval late last week to the immunotherapy afamitresgene autoleucel (afami-cel) for the treatment of adults with synovial sarcoma, a rare soft tissue..
Repotrectinib has received accelerated approval from the USFDA for adult and pediatric patients with NTRK gene fusion-positive solid tumors
June 2024: The Food and Drug Administration (FDA) has given accelerated approval to repotrectinib (AUGTYRO, Bristol-Myers Squibb Company) for the treatment of solid tumors in adult and pediatric patients aged 12 and abov..
Lutetium Lu 177 dotatate is approved by USFDA for pediatric patients 12 years and older with GEP-NETS
Lutetium Lu 177 dotatate is approved by USFDA for pediatric patients The Food and Drug Administration has approved lutetium Lu 177 dotatate (Lutathera, Advanced Accelerator Applications USA, Inc., a Novartis company) as a way to ..
Abecma, BCMA
Understanding BCMA: A Revolutionary Target in Cancer Treatment
Introduction In the ever-evolving realm of oncological treatment, scientists persistently seek out unconventional targets that can amplify the effectiveness of interventions while mitigating unwanted repercussions. One such intri..
How Targeted Therapy is Revolutionizing Advanced Cancer Treatment?
Targeted Therapy in Advanced Cancer: A Precision Approach to Treatment Targeted therapy has significantly transformed the therapeutic options for advanced cancer in the field of oncology. Targeted therapy differs from con..
Survivorship and long-term care in advanced cancers
Understanding Survivorship in the Context of Advanced Cancers Survivorship, once a term associated predominantly with those in remission, has evolved. Today, it encompasses a multifaceted journey that includes i..
Cancer statistics in India 2024: Incidence, estimates and projections
Cancer incidence, statistics, and estimates 2024: Results from National Cancer Registry Program Cancer incidence rates are increasing at an alarming rate in India, and are anticipated to grow by 12% over the next five years. As a..
India
India declared cancer capital of the world – Apollo report
India declared cancer capital of the world India was designated as the "cancer capital of the world" in the 4th edition of Apollo Hospitals' Health of the Nation Report, which was published on World Health Day 2024. According ..